Abstract: A method for detecting glutaraldehyde in a water sample in which Au-BSA nanoclusters have been introduced is provided. In the method, the water sample is mixed with the Au-BSA nanoclusters to form a mixture. The mixture is incubated for 2 to 10 minutes, and the glutaraldehyde present in the mixture reacts with the Au-BSA nanoclusters and causes fluorescence quenching of the Au-BSA nanoclusters. Then a fluorescence intensity of the quenched Au-BSA nanoclusters in the mixture is measured at an emission wavelength of 675 nm. A presence and concentration of glutaraldehyde in the water sample is then determined by comparing the measured fluorescence intensity of the quenched Au-BSA nanoclusters at the emission wavelength of 675 nm with fluorescence intensity values of calibration samples comprising Au-BSA nanoclusters and known glutaraldehyde concentrations.

Abstract: A plant extraction method includes the following steps: 1) preparation of a crude plant extraction solution; 2) separation of the crude extraction solution through a cation resin and an optional anion resin to obtain a collection solution; 3) concentration of the collection solution obtained in step 2); 4) alcohol precipitation of the concentration solution obtained in step 3); and optionally, step 5) concentration and drying. The method can effectively reduce the content of heavy metals in an extract, and reduce the amount of ethanol used in extraction, thereby improving the product quality and lowering the production cost, and the efficiency and safety of industrial production are improved. The extract obtained by this method can be used to prepare drugs for lowering blood lipid, treating abnormal glucose tolerance, treating diseases related to abnormal blood glucose, or regulating intestinal flora, and can be processed into food products, health-care products or drinks.

Abstract: A message forwarding method, a system, a device, a node device, and a storage medium are disclosed. The message forwarding method, applied to a first node device, may include: carrying a time sensitive networking (TSN) profile in a segment routing header of a segment routing Internet protocol version 6 (SRv6) service message of deterministic networking; and sending the SRv6 service message carrying the TSN profile.

Abstract: Methods and systems are disclosed for analyzing interactions between low-frequency oscillations and high-frequency activity in electromagnetic brain signals such as EEG, MEG, SEEG, and ECoG signals in subjects in real-time that does not depend on the signals being contained within narrow frequency bands, sinusoidal, sustained and monolithic. The disclosed methods and systems can be applied to electromagnetic brain signals to detect brain activity alterations associated with neurological and psychiatric diseases.

Abstract: The present application discloses methods for detecting and quantifying tetrakis(hydroxymethyl) phosphonium sulfate (THPS) in a water sample. In the methods, a water sample is mixed with a KMnO4 solution to form a mixture. An intensity of KMnO4 absorption in the mixture is then measured at a wavelength of 525 nm. The measured intensity is normalized by subtracting a background intensity at a wavelength of 650 nm. The presence and concentration of THPS in the water sample can then be determined by comparing the normalized intensity with intensity values of KMnO4 absorption of calibration samples comprising KMnO4 and known THPS concentrations.

Abstract: The present application discloses methods for detecting and quantifying tetrakis(hydroxymethyl) phosphonium sulfate (THPS) in a water sample. In the methods, a water sample is mixed with a KMnO4 solution to form a mixture. An intensity of KMnO4 absorption in the mixture is then measured at a wavelength of 525 nm. The measured intensity is normalized by subtracting a background intensity at a wavelength of 650 nm. The presence and concentration of THPS in the water sample can then be determined by comparing the normalized intensity with intensity values of KMnO4 absorption of calibration samples comprising KMnO4 and known THPS concentrations.

Abstract: A method for detecting glutaraldehyde in a water sample in which Au-BSA nanoclusters have been introduced is provided. In the method, the water sample is mixed with the Au-BSA nanoclusters to form a mixture. The mixture is incubated for 2 to 10 minutes, and the glutaraldehyde present in the mixture reacts with the Au-BSA nanoclusters and causes fluorescence quenching of the Au-BSA nanoclusters. Then a fluorescence intensity of the quenched Au-BSA nanoclusters in the mixture is measured at an emission wavelength of 675 nm. A presence and concentration of glutaraldehyde in the water sample is then determined by comparing the measured fluorescence intensity of the quenched Au-BSA nanoclusters at the emission wavelength of 675 nm with fluorescence intensity values of calibration samples comprising Au-BSA nanoclusters and known glutaraldehyde concentrations.

Abstract: Provided is an anti-PD-L1 monoclonal antibody. The antibody can be used to prepare a drug for preventing or treating a disease related to PD-L1.

Abstract: Methods and systems are provided for a cathode material for lithium ion batteries. In one example, the cathode material may include a lithium mixed metal oxide core and a surface coating surrounding the core. Optionally, a passivating layer may continuously surround the surface coating. In some examples, the surface coating or surface layer may include a sacrificial lithium source, a lithium-based active cathode catalyst, or a combination thereof. In other examples, methods are provided for manufacturing the cathode material for use in a lithium ion battery.

Abstract: The present invention provides an anti-PD-L1/VEGF bispecific antibody and a use thereof. Specifically, the present invention provides a bifunctional antibody, comprising: (a) anti-PD-L1 antibody or element; and (b) an anti-VEGF antibody or element linked to the anti-PD-L1 antibody or element. The bifunctional antibody of the present invention can simultaneously bind to VEGF and PD-L1, thereby exerting a therapeutic effect on VEGF and PD-L1-positive tumor cells (especially malignant tumor cells).

Abstract: A robot control method, a device, and a remote control system. A mobile terminal establishes a connection to a robot by scanning a two-dimensional code and by a local area network. A remote monitoring and control center connects to the mobile terminal by a wide area network, and when the mobile terminal and the remote monitoring and control center send information to each other, the mobile terminal breaks off connection with the robot, thereby ensuring information transmission security. Operation instruction information from a user on an operation interface is acquired, the operation instruction information comprising a control parameter and an action execution parameter, and on based on the set control parameter and the set action execution parameter, first control instruction information is generated, and sent to the robot by a wireless communications network, in order to cause the robot to execute a corresponding action based on the first control instruction information.

Abstract: The present invention relates to anti-IL-23p19 binding compounds, in particular new humanized anti-IL-23p19 antibodies and therapeutic and diagnostic methods and compositions for using the same.

Abstract: The present invention provides an antibody targeted to interleukin 17A (IL-17A), preparation method and the use thereof. In particular, the invention provides a novel anti-IL-17A monoclonal antibody. The antibody of the present invention is capable of binding IL-17A antigen with high specificity, has high affinity and low immunogenicity, and is used for preparing a medicament for preventing or treating an IL-17A-related disease such as various inflammatory or autoimmune diseases.

Abstract: An apparatus to simulate biocide performance in crude oil pipeline conditions is disclosed. The apparatus includes: a reactor to simulate a two-phase crude oil pipeline which includes a crude oil phase above a water phase. The reactor has an agitator to control a flow of the water phase in the reactor in response to a motor that drives an agitation rate of the agitator. A crude oil inlet supplies crude oil to the reactor for the crude oil phase. A water inlet supplies water to the reactor for the water phase. A control circuit is configured by code to control a proportion of the water to the crude oil supplied to the reactor and to control the motor to drive a desired agitation rate of the agitator. A biocide inlet supplies biocide to the reactor. A water sample outlet enables sampling of the water phase of the reactor.

Abstract: The embodiments of the present disclosure provide a data packet processing method and apparatus, a storage medium and an electronic device. The method includes that: a Bit Index Explicit Replication (BIER) Multicast Identifier (BMID) information of a data packet is set, wherein the BMID information is used for indicating a multicast channel to which the data packet belongs; and the BMID information is sent to a Bit-Forwarding Ingress Router (BFIR). Through the solution in the embodiments of the present disclosure, the technical problem in the related art that a node receives duplicate data packets is solved, duplicate data packets may be prevented, and data transmission efficiency is improved.

Abstract: Methods and systems are provided for fabricating a large format lithium ion electrochemical cell that includes an anode and a cathode. In one example, the anode is prepared via loading the anode to a predetermined anode loading amount, followed by electrochemical pre-lithiation of the anode via electrically coupling an auxiliary electrode to the anode where lithium is transferred to the anode through an electrolyte solution from the auxiliary electrode. In this way, pre-lithiation of the anode may be improved, which may in turn increase a capacity of the large format lithium ion electrochemical cell.

Abstract: The present invention provides an antibody targeted to interleukin 17A (IL-17A), preparation method and the use thereof. In particular, the invention provides a novel anti-IL-17A monoclonal antibody. The antibody of the present invention is capable of binding IL-17A antigen with high specificity, has high affinity and low immunogenicity, and is used for preparing a medicament for preventing or treating an IL-17A-related disease such as various inflammatory or autoimmune diseases.

Abstract: A method of making acrylamide-acrylic acid copolymers in water-in-oil latices is described. The method results in a copolymer having randomly distributed carboxylate functionalities and is suitable for ionic crosslinking. The copolymers and their ionically crosslinked counterparts are useful for enhanced oil recovery processes.

Abstract: Highly random acrylamide-acrylic acid copolymers are described. Ionic crosslinking of the highly random copolymers in dilute solution results in improved viscosity and gel strength compared to copolymers prepared by conventional methods. The ionically crosslinked copolymers are useful in enhanced oil recovery processes.

Abstract: The present invention relates to anti-IL-23p19 binding compounds, in particular new humanized anti-IL-23p19 antibodies and therapeutic and diagnostic methods and compositions for using the same.